Efficacy and safety of carbon ion radiotherapy in 16 fractionations for prostate cancer
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000003827
- Lead Sponsor
- Gunma University Heavy Ion Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of pelvic irradiation 2) History of TUR-Bt or HIFU 3) HIstory of chemotherapy 4 weeks before treatment 4) life expectancy less than 6 months 5) Active double cancer 6) neoadjuvant hormonal therapy more than 8 months 7) hormone-refractory prostate cancer 8) difficulty with planned hormonal therapy 9) Corticosteroid or antiandrogen therapy for concomitant disease 10) severe comcomitant disease 11) other medically or psychologically unsuitable reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemocal relapse-free rate at 5 years
- Secondary Outcome Measures
Name Time Method